Reduced Intensity Haploidentical Transplant for Hematological Malignancies

NCT01162096 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancies

Interventions

DEVICE: Haploidentical Allogeneic Transplantation

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University